Guillaume Canaud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Guillaume Canaud has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
E. Thervet
Université Paris Descartes, Paris, France
5 shared publicationsF. Martinez
Université Paris Descartes, Paris, France
5 shared publications- Julien Zuber
Department of Kidney and Metabolic Diseases, Transplantation and Clinical Immunology, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Université Paris Cité, Paris, France; Université Paris Cité, INSERM U1151, CNRS UMR 8253, Institut Necker Enfants Malades, Paris, 75015, France; FHU Transvir, Région île de France
5 shared publications C. Legendre
Université Paris Descartes, Paris, France
4 shared publicationsChristophe Legendre
3 shared publicationsFrank Martinez
3 shared publications
Latest Publications
- Open Access
- 17 August 2011
- Published by IntechOpen
Therapeutic Approach to Focal and Segmental Glomerulosclerosis (FSGS) Recurrence in Kidney Transplant Recipients
- 17 August 2011
- Published by IntechOpen
Open AccessTherapeutic Approach to Focal and Segmental Glomerulosclerosis (FSGS) Recurrence in Kidney Transplant Recipients
- Open Access
- 1 September 2010
- Published by Elsevier in American Journal of Transplantation
- Vol. 10 (9) , 2051-2060
Severe Vascular Lesions and Poor Functional Outcome in Kidney Transplant Recipients with Lupus Anticoagulant Antibodies
- 1 September 2010
- Published by Elsevier in American Journal of Transplantation
- Vol. 10 (9) , 2051-2060
Open AccessSevere Vascular Lesions and Poor Functional Outcome in Kidney Transplant Recipients with Lupus Anticoagulant Antibodies
- 31 July 2010
- Published by Elsevier in Transplantation Reviews
- Vol. 24 (3) , 121-128
Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients
- 31 July 2010
- Published by Elsevier in Transplantation Reviews
- Vol. 24 (3) , 121-128
Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients
- Open Access
- 25 June 2010
- Published by Elsevier in American Journal of Transplantation
- Vol. 10 (7) , 1710-1715
Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?
- 25 June 2010
- Published by Elsevier in American Journal of Transplantation
- Vol. 10 (7) , 1710-1715
Open AccessTherapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?
- 1 March 2010
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 55 (3) , 558-565
Glomerular Collapse Associated With Subtotal Renal Infarction in Kidney Transplant Recipients With Multiple Renal Arteries
- 1 March 2010
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 55 (3) , 558-565
Glomerular Collapse Associated With Subtotal Renal Infarction in Kidney Transplant Recipients With Multiple Renal Arteries
- 22 September 2009
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 25 (4) , 1321-1328
Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS)
Introduction. Recurrence of nephrotic-range proteinuria in patients with idiopathic nephrotic syndrome (INS) and focal and segmental glomerulosclerosis (FSGS) on native kidneys is associated with poor graft survival. Identification of risk factors for recurrence is therefore an important issue. In 2004, Columbia University introduced a histological classification of FSGS that identifies five mutually exclusive variants. In non-transplant patients, the Columbia classification appears to predict the outcome and response to treatment better than clinical characteristics alone. However, the predictive value of this classification to assess the risk of recurrence after transplantation has not been addressed. We retrospectively studied 77 patients with INS and FSGS on native kidneys who underwent renal transplantation. Of these, 42 recipients experienced recurrence of nephrotic range proteinuria. At time of recurrence, minimal-change disease (MCD) was the main histological feature. On serial biopsies, the incidence of MCD decreased over time, while the incidence of FSGS variants increased. The variant type observed in the native kidneys was not predictive of either recurrence or type of FSGS seen on the allograft. Patients with complete and sustained remission did not developed FSGS. In conclusion, the Columbia classification is of no help in predicting recurrence after renal transplantation or histological lesions in the case of recurrence of proteinuria.
- 22 September 2009
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 25 (4) , 1321-1328
Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS)
Introduction. Recurrence of nephrotic-range proteinuria in patients with idiopathic nephrotic syndrome (INS) and focal and segmental glomerulosclerosis (FSGS) on native kidneys is associated with poor graft survival. Identification of risk factors for recurrence is therefore an important issue. In 2004, Columbia University introduced a histological classification of FSGS that identifies five mutually exclusive variants. In non-transplant patients, the Columbia classification appears to predict the outcome and response to treatment better than clinical characteristics alone. However, the predictive value of this classification to assess the risk of recurrence after transplantation has not been addressed. We retrospectively studied 77 patients with INS and FSGS on native kidneys who underwent renal transplantation. Of these, 42 recipients experienced recurrence of nephrotic range proteinuria. At time of recurrence, minimal-change disease (MCD) was the main histological feature. On serial biopsies, the incidence of MCD decreased over time, while the incidence of FSGS variants increased. The variant type observed in the native kidneys was not predictive of either recurrence or type of FSGS seen on the allograft. Patients with complete and sustained remission did not developed FSGS. In conclusion, the Columbia classification is of no help in predicting recurrence after renal transplantation or histological lesions in the case of recurrence of proteinuria.
- Open Access
- 16 April 2009
- Published by Elsevier in American Journal of Transplantation
- Vol. 9 (5) , 1081-1086
Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study
- 16 April 2009
- Published by Elsevier in American Journal of Transplantation
- Vol. 9 (5) , 1081-1086
Open AccessIntensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study
- 4 December 2008
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 24 (4) , 1325-1327
Early conservative intervention for candida contamination of preservative fluid without allograft nephrectomy
Fungal contamination of kidney allograft preservative fluid can lead to renal arteritis and arterial wall rupture. We have evaluated a conservative management strategy based onearly antifungal therapy, rigorous morphological monitoring of the graft artery and surgical second look (SSL). Since November 2004, preservative fluid was routinely cultured on specific media for all kidney transplant recipients. In 8/474 cases, results were positive for Candida (albicans 5, glabrata 2, tropicalis 1). Two patients also had candida infection of drainage fluid leading to the diagnosis of operative site infection. Radiological and surgical examinations of the renal graft artery were normal in all cases and nephrectomy was not required. At 12 months, all patients were alive with a functioning allograft. Early antifungal therapy with microbiological and morphological follow-up should be recommended as soon as contamination is detected, but SSL is advised only in patients with risk factors for arterial anomalies.
- 4 December 2008
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 24 (4) , 1325-1327
Early conservative intervention for candida contamination of preservative fluid without allograft nephrectomy
Fungal contamination of kidney allograft preservative fluid can lead to renal arteritis and arterial wall rupture. We have evaluated a conservative management strategy based onearly antifungal therapy, rigorous morphological monitoring of the graft artery and surgical second look (SSL). Since November 2004, preservative fluid was routinely cultured on specific media for all kidney transplant recipients. In 8/474 cases, results were positive for Candida (albicans 5, glabrata 2, tropicalis 1). Two patients also had candida infection of drainage fluid leading to the diagnosis of operative site infection. Radiological and surgical examinations of the renal graft artery were normal in all cases and nephrectomy was not required. At 12 months, all patients were alive with a functioning allograft. Early antifungal therapy with microbiological and morphological follow-up should be recommended as soon as contamination is detected, but SSL is advised only in patients with risk factors for arterial anomalies.